Relationship between BMI and β-hCG levels with hyperemesis gravidarum in Manado, Indonesia
Downloads
Objectives: The main objective of this study was to determine the relationship between BMI and β-HCG levels with hyperemesis gravidarum.
Materials and Methods: This study was a case control study which compares between BMI and β-Hcg levels of patients with hyperemesis gravidarum and without hyperemesis gravidarum. This study was conducted at Obstetric and Ginecology Department of Medical Faculty of Sam Ratulangi University in Manado. This study was conducted on September - November 2018 and participated by 33 pregnant women with hyperemesis gravidarum and 33 pregnant women without hyperemesis gravidarum which were included in accordance to the inclusion criteria and signed the informed consent to participate in this study.
Results: The percentage of patients with Hyperemesis Gravidarum within the age group of 20 -35 years old were 23 patients (69.69%). The highest number of patients without Hyperemesis Gravidarum were [VL1] within age group of 20 - 35 years old as many [VL2] as 28 patients (84.84%). Hyperemesis Gravidarum was found the most in normal BMI group, which was 26 patients (78.78%). The patients without hyperemesis gravidarum were also found in the highest number in the normal BMI group, 21 patients (63.63%). T-test showed that there was no significant difference in BMI of group with postive HEG and negative HEG (p = 0.027). Spearman Correlation Test had been conducted to show relationship between β-hCG levels, and there was a strong correlation between gestational age and β-Hcg levels (r = 0,764 ; p = 0,000), which means β-hGG level increased along with gestational age.
Conclusion:There was significant relationship between β-hCG and Hyperemesis Gravidarum. There was also a significant relationship between gestational age and β-hCG Levels which mean the increase of β-hGG level is along with the increase of gestational age. Tere was no significant relationship between BMI and Hyperemesis Gravidarum.Källen B, Lundberg G, Aberg A. Relationship between vitamin use, smoking, and nausea and vomiting of pregnancy. Acta Obstet Gynecol Scand 2013;82:916-20.
Lacroix R, Eason E, Melzack R. Nausea and vomiting during pregnancy: a prospective study of its frequency, intensity, and patterns of change. Am J Obstet Gynecol 2010; 182:931-7.
Källen B. Hyperemesis during pregnancy and delivery outcome: a registry study. Eur J Obstet Gynecol Reprod Biol 2014;26:291-302
Bailit JL. Hyperemesis gravidarum: epidemi-ologic findings from a large cohort. Am J Obstet Gynecol 2015;193:811-4.
Fell DB, Dodds L, Joseph KS, Allen VM, But-ler B. Risk factors for hyperemesis gravidarum requiring hospital admission during pregnancy. Obstet Gynecol 2010;107:277-84.
Adams MM, Harlass FE, Sarno AP, Read JA, Rawlings JS. Antenatal hospitalization among enlisted servicewomen. Obstet Gynecol 2014;84:35-9.
Gazmararian JA, Petersen R, Jamieson DJ, et al. Hospitalizations during pregnancy among managed care enrollees. Obstet Gynecol 2012;100:94-100.
Basso O, Olsen J. Sex ratio and twinning in women with hyperemesis or pre-eclampsia. Epidemiology 2011;12:747-9.
Schiff MA, Reed SD, Daling JR. The sex ratio of pregnancies complicated by hospitalisation for hyperemesis gravidarum. BJOG 2014;111: 27-30.
Franko DL, Spurrell EB. Detection and man-agement of eating disorders during pregnancy. Obstet Gynecol 2010;95:942-6.
Rochelson B, Vohra N, Darvishzadeh J, Pa-gano M. Low prepregnancy ideal weight: height ratio in women with hyperemesis gravidarum. J Reprod Med 2013;48:422-4.
Grooten IJ, Painter RC, Pontesilli M, et al. Weight loss in pregnancy and cardiometabolic profile in childhood: findings from a longitudinal birth cohort. BJOG Int J Obstet Gynaecol. 2014;122(12):1664–1673.
Ben-Aroya Z, Lurie S, Segal D, Hallak M, Glezerman M. Association of nausea and vom-iting in pregnancy with lower body mass index. Eur J Obstet Gynecol Reprod Biol 2015; 118:196-8.
Vilming B, Nesheim BI. Hyperemesis gravi-darum in a contemporary population in Oslo. Acta Obstet Gynecol Scand 2000;79:640-3.
Lagiou P, Tamimi R, Mucci LA, Trichopou-los D, Adami HO, Hsieh CC. Nausea and vom-iting in pregnancy in relation to prolactin, estro-gens, and progesterone: a prospective study. Obstet Gynecol 2013;101:639-44.
National Board of Health and Welfare, Cen-tre for Epidemiology. The Swedish Medical Birth Register: a summary of content and quality [on-line]. Last accessed: February 1, 2018. Available at: http://www.sos.se/FULLTEXT/112/2003-112-3/2003-112-3.pdf.
National Board of Health and Welfare, Cen-tre for Epidemiology. The Swedish Hospital Dis-charge Register [on-line]. Available at: http://www.sos.se/ epc/english/ParEng.htm.
Mantel N, Haenszel W. Statistical aspects of the analyses of data from retrospective stud-ies of disease. J Nat Cancer Inst 2010;22: 719-48.
Miettinen OS. Simple interval estimation of risk ratio. Am J Epidemiol 2010;100:515-6.
Källen B, Mottet I. Delivery outcome after the use of meclizine in early pregnancy. Eur J Epidemiol 2013;18:665-9.
Goodwin TM. Hyperemesis gravidarum. Clin Obstet Gynecol 2008;41:597-605.
Depue RH, Bernstein L, Ross RK, Judd HL, Henderson BE. Hyperemesis gravidarum in re-lation to estradiol levels, pregnancy outcome, and other maternal factors: a seroepidemio-logic study. Am J Obstet Gynecol 2007; 156:1137-41.
Cedergren MI. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol 2014;103:219-24.
Stenman, U.H.; Alfthan, H. Determination of human chorionic gonadotropin. Best Pract. Res. Clin. Endocrinol. Metab. 2013, 27, 783–793.
Niebyl, J. R.. Nausea and Vomiting in Pregnancy.(2010). Therapy, 15441550..
Forget, Evelyn L. The Town with No Poverty: Using Health Administration Data to Revisit Outcomes of a Canadian Guaranteed Annual Income Field Experiment.2016
Saputra, Wiko, et.al. Efektivitas Kebijakan Daerah dalam Penurunan Angka Kematian Ibu dan Bayi., 2013.
Lanry Mason. Sustainable Development Knowledge Platform. SDGs & Topics. New York 2015
Badan Pusat Statistik, Badan Kependudukan dan Keluarga Berencana Nasional, Kementerian Kesehatan, Measure DHS ICF International. Survei Demografi dan Kesehatan Indonesia tahun 2012. Jakarta : Badan Pusat Statistik. 2012.
Kementerian Kesehatan Republik Indonesia. Profil Kesehatan Indonesia tahun 2015. Jakarta : Kementerian Kesehatan Republik Indonesia. 2016.
Fournier, T.; Guibourdenche, J.; Evain-Brion, D. Review: hCGs: Different sources of production, different glycoforms and functions. Placenta 2015, 36, S60–S65.
Hay, D.L.; Lopata, A. Chorionic gonadotropin secretion by human embryos in vitro. J. Clin. Endocrinol. Metab. 1988, 67, 1322–1324.
Hay, D.L. Placental histology and the production of human choriogonadotrophin and its subunits in pregnancy. Br. J. Obstet. Gynaecol. 1988, 95, 1268–1275.
Zygmunt, M.; Herr, F.; Keller-Schoenwetter, S.; Kunzi-Rapp, K.; Munstedt, K.; Rao, C.V.; Lang, U.; Preissner, K.T. Characterization of human chorionic gonadotropin as a novel angiogenic factor. J. Clin. Endocrinol. Metab. 2002, 87, 5290–5296.
Ambrus, G.; Rao, C.V. Novel regulation of pregnant human myometrial smooth muscle cell gap junctions by human chorionic gonadotropin. Endocrinology 1994, 135, 2772–2779.
Hubungan Dukungan Sosial dengan Emesis Gravidarum pada Kehamilan Trimester Pertama di RSUP dr. Sardjito Yogyakarta Tahun 2001, Yogyakarta, Yogyakarta.
Hubungan Dukungan Sosial dengan Emesis Gravidarum pada Kehamilan Trimester Pertama di RSUP dr. Sardjito Yogyakarta Tahun 2001, Yogyakarta, Yogyakarta
Jurnal Obstretika Scientia Vol. 2 No. 1 Juni 2014.
Sulistyaningsih. 2011. Metodologi Penelitian Kebidanan Kuantitatif – Kualitatif. Yogyakarta: Graha Ilmu
Tiran, Denise. 2006. Mual & Muntah Kehamilan. Jakarta : EGC.
Schumacher, A.; Heinze, K.; Witte, J.; Poloski, E.; Linzke, N.; Woidacki, K.; Zenclussen, A.C. Human chorionic gonadotropin as a central regulator of pregnancy immune tolerance. J. Immunol. 2013, 190, 2650–2658. [CrossRef] [PubMed]
Bansal, A.S.; Bora, S.A.; Saso, S.; Smith, J.R.; Johnson, M.R.; Thum, M.Y. Mechanism of human chorionic gonadotrophin-mediated immunomodulation in pregnancy. Expert Rev. Clin. Immunol. 2012, 8, 747–753. [CrossRef] [PubMed]
Nisula, B.C.; Blithe, D.L.; Akar, A.; Lefort, G.; Wehmann, R.E. Metabolic fate of human choriogonadotropin. J. Steroid Biochem. 1989, 33, 733–737. [CrossRef]
Cole, L.A. Immunoassay of human chorionic gonadotropin, its free subunits, and metabolites. Clin. Chem. 1997, 43, 2233–2243.
1. Copyright of the article is transferred to the journal, by the knowledge of the author, whilst the moral right of the publication belongs to the author.
2. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution-Non Commercial-Share alike (CC BY-NC-SA), (https://creativecommons.org/licenses/by-nc-sa/4.0/)
3. The articles published in the journal are open access and can be used for non-commercial purposes. Other than the aims mentioned above, the editorial board is not responsible for copyright violation
The manuscript authentic and copyright statement submission can be downloaded ON THIS FORM.
